Keri Vaughan has extensive experience in clinical operations within the pharmaceutical industry, currently serving as Head of Global Clinical Operations North America at Viatris since May 2018. In this role, Keri leads clinical initiatives across various therapeutic areas, including endocrinology and oncology, while managing significant integration efforts during the Mylan/Upjohn transition. Keri's previous positions include Director of Clinical Operations at Mylan Inc., where oversight was provided for general medicine projects, and Director of General Medicine at Pharma-Start LLC, supporting global endocrinology programs. Additional expertise was developed as Executive Director of Clinical Operations at Akesis, Senior Director of Global Project Management at ReSearch Pharmaceutical Services, and Project Director at PRA International. Keri's career commenced at Covance Inc., managing clinical research projects from inception to completion. Keri holds a BA in Anthropology from The Ohio State University.